Low-dose anti-thymocyte globulin reduce severe acute and chronic graft-versus-host disease after allogeneic stem cell transplantation-Reference-Cited by-同舟云学术

Low-dose anti-thymocyte globulin reduce severe acute and chronic graft-versus-host disease after allogeneic stem cell transplantation

Published:2017-01-06 Issue:4 Volume:143 Page:709-715
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Imataki Osamu,Matsumoto Kensuke,Uemura Makiko

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-016-2329-7.pdf

Reference32 articles.

1. Bacigalupo A, Lamparelli T, Bruzzi P et al (2001) Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood 98:2942–2947

2. Bacigalupo A, Sormani MP, Lamparelli T et al (2004) Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation. Haematologica 89:1238–1247

3. Basara N, Baurmann H, Kolbe K et al (2005) Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group. Bone Marrow Transpl 35:1011–1018

4. Bensinger WI, Weaver CH, Appelbaum FR et al (1995) Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655–1658

5. Champlin R, Ho W, Gale RP (1983) Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. N Engl J Med 308:113–118

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High Risk of Recurrence of Malignancy Noted in Four-day rATG Regimen After Allogeneic PBSCT From Matched Sibling Donors;Transplantation and Cellular Therapy;2022-11

2. Effect of antithymocyte globulin on chronic GVHD and prognosis of allogeneic hematopoietic stem cell transplantation;Japanese Journal of Transplantation and Cellular Therapy;2022

3. Graft-Versus-Host Disease Prophylaxis Using Low-Dose Antithymocyte Globulin in Peripheral Blood Stem Cell Transplantation—A Matched-Pair Analysis;Transplantation and Cellular Therapy;2021-12

4. Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donors;Bone Marrow Transplantation;2021-05-07

5. High lymphocyte counts before antithymocyte globulin administration predict acute graft-versus-host disease;Annals of Hematology;2020-11-19